Tumour Thrombosis

Tumour thrombosis is a serious complication that occurs when cancer cells grow directly into blood vessels, forming a blockage made of tumour tissue rather than a typical blood clot.

tumor thrombus, tumoral thrombosis, intravascular tumor extension

Table of contents

• What is tumour thrombosis?
• Which cancers most commonly cause tumour thrombosis?
• Symptoms and complications
• Diagnosis and imaging
• Impact on prognosis and staging
• Treatment approaches

What is tumour thrombosis?

Tumour thrombosis is defined as the extension of tumour cells into a blood vessel. Unlike a regular blood clot, which is made up of platelets (small blood cells that help stop bleeding) and fibrin (a protein that forms clots), a tumour thrombus consists of an organized collection of cancer cells^[1][4].

This condition can affect any blood vessel but is more commonly found in veins. When it occurs, it represents intravascular tumour extension, meaning the cancer is growing directly into the vessel rather than simply pressing against it from the outside^[2].

Tumour thrombosis is different from cancer-associated blood clots that form separately from the tumour. Understanding this difference is important because it affects how doctors approach treatment and what they expect for the patient’s outlook^[4].

Which cancers most commonly cause tumour thrombosis?

Tumour thrombosis can occur in many different types of cancer, but certain cancers have a much higher tendency to grow into blood vessels. The cancers with the highest likelihood of causing tumour thrombosis include^[1][3]:

• Renal cell carcinoma (kidney cancer) – this type of cancer has a known tendency for vascular invasion, occurring in approximately 10% of cases
• Wilms’ tumour – a type of kidney cancer that occurs mainly in children
• Hepatocellular carcinoma (liver cancer)
• Adrenal cortical carcinoma – cancer of the adrenal glands

Among these, renal cell carcinoma is the 9th most common type of cancer diagnosed in the United States and was projected to result in 14,400 deaths in 2017. The presence of tumour thrombus in this cancer changes how the disease is staged, affects the prognosis, and influences the surgical approach doctors take^[1].

In patients with renal cell carcinoma and hepatocellular carcinoma, tumour thrombosis is frequently encountered and often involves the abdominal blood vessels, including the renal vein (the vein draining the kidney), portal vein (the vein bringing blood to the liver), and the inferior vena cava (the large vein that carries blood from the lower body to the heart)^[4].

• Blood vessels (veins and arteries)
• Renal vein
• Portal vein
• Inferior vena cava
• Heart
• Lungs

Symptoms and complications

Tumour thrombosis may not always cause noticeable symptoms. In many cases, it is detected incidentally during imaging tests performed for other reasons. However, when symptoms do occur, they can vary depending on where the tumour thrombus is located^[1][4].

When tumour thrombosis does cause symptoms, patients may experience^[1]:

• Varicocele (enlarged veins in the scrotum)
• Lower extremity swelling
• Cardiac dysfunction (problems with heart function)
• Pulmonary embolism (blockage in the lung arteries)
• Budd-Chiari syndrome (blockage of the veins draining the liver)

The presence of tumour thrombus can have significant clinical implications. It can be challenging to differentiate from a regular bland thrombus on initial evaluation, which is why imaging studies play such an important role in diagnosis^[4].

Diagnosis and imaging

Imaging plays a crucial role in both detecting tumour thrombus and distinguishing it from a regular blood clot. This differentiation is essential because the two conditions require different treatment approaches^[1][3].

Doctors use various imaging techniques to diagnose tumour thrombosis. These tools help them see inside blood vessels and determine whether a blockage is caused by cancer cells or a regular clot. The detailed pictures these tests provide are essential for planning the best treatment strategy^[1].

Though tumour thrombus is often detected incidentally during routine imaging, its presence has important implications for how the cancer is staged and treated. Medical professionals must carefully evaluate imaging results to make accurate diagnoses^[4].

Impact on prognosis and staging

The presence of tumour thrombosis markedly worsens a patient’s prognosis and significantly impacts the treatment approach. When cancer extends into blood vessels, it changes the stage of the disease, which is a key factor in determining treatment options and predicting outcomes^[1][2][3].

Tumour thrombosis can significantly worsen a cancer prognosis. Its presence affects how doctors classify the disease and what treatments they recommend. The extension of cancer into blood vessels represents a more advanced stage of disease spread^[2].

In renal cell carcinoma, for example, when tumour thrombus is present in the renal vein or extends into the inferior vena cava, the cancer is staged as T3. The specific substage depends on how far the thrombus extends: T3a if it’s only in the renal vein, or T3b if it extends into the inferior vena cava below the diaphragm^[3].

The presence of tumour thrombus changes not only the stage but also the prognosis and treatment approach that doctors recommend. This is why accurate detection and characterization of tumour thrombus through imaging is so important^[1].

Treatment approaches

The treatment of tumour thrombosis requires a comprehensive approach that addresses both the cancer and the vascular involvement. The optimal management, including decisions about whether to use anticoagulation (blood-thinning medication), remains an area where medical understanding continues to develop^[4].

Endovascular methods (procedures performed inside blood vessels) play a large role in treatment. These minimally invasive techniques allow doctors to address the tumour thrombus without the need for major open surgery in some cases^[1][3].

The presence of tumour thrombosis impacts the surgical approach when surgery is appropriate. Surgeons must carefully plan how to remove not just the tumour but also the extension into the blood vessels. This often requires specialized techniques and expertise^[1].

Treatment decisions are individualized based on the type of cancer, the extent of tumour thrombus, the patient’s overall health, and other factors. A multidisciplinary team of specialists typically works together to determine the best approach for each patient^[4].